{
    "organizations": [],
    "uuid": "4a058974cb413f9480a3f5680a956c25d16f5c9f",
    "author": "",
    "url": "https://www.reuters.com/article/brief-protagonist-therapeutics-q4-loss-p/brief-protagonist-therapeutics-q4-loss-per-share-0-15-idUSASB0C99H",
    "ord_in_thread": 0,
    "title": "BRIEF-Protagonist Therapeutics Q4 Loss Per Share $0.15",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 7, 2018 / 9:15 PM / Updated 9 minutes ago BRIEF-Protagonist Therapeutics Q4 Loss Per Share $0.15 Reuters Staff March 7 (Reuters) - Protagonist Therapeutics Inc: * PROTAGONIST THERAPEUTICS REPORTS FOURTH QUARTER AND YEAR-END 2017 FINANCIAL RESULTS * PROTAGONIST THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.15 * PROTAGONIST THERAPEUTICS - ANTICIPATE HAVING ENOUGH CASH, CASH EQUIVALENTS, INVESTMENTS TO SUPPORT OPERATIONS THROUGH 2019  ",
    "published": "2018-03-07T23:12:00.000+02:00",
    "crawled": "2018-03-07T23:33:20.046+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "updated",
        "minute",
        "ago",
        "therapeutic",
        "q4",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "march",
        "reuters",
        "protagonist",
        "therapeutic",
        "inc",
        "protagonist",
        "therapeutic",
        "report",
        "fourth",
        "quarter",
        "financial",
        "result",
        "protagonist",
        "therapeutic",
        "inc",
        "qtrly",
        "loss",
        "per",
        "share",
        "protagonist",
        "therapeutic",
        "anticipate",
        "enough",
        "cash",
        "cash",
        "equivalent",
        "investment",
        "support",
        "operation"
    ]
}